Category: Research

James F. Howard, Jr, MD, in the UNC Department of Neurology is the lead primary investigator in the CHAMPION-MG trial for Ultomiris (ravulizumab-cwvz) as a treatment for adults with generalised myasthenia gravis who are anti-acetylcholine receptor antibody-positive, which represents 80% of people living with the disease.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the ADAPT+ trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

NC TraCS awarded funding for a $5K-$50K grant application submitted by Rebecca Traub, MD and Xiaoyan Li, MD, PhD.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was lead investigator in UCB's RAISE trial to evaluate zilucoplan as a treatment for generalized myasthenia gravis in adults.

Dr. Timothy Gershon is co-corresponding author of new research that appeared in Sciences Advances, January 26, 2022.

James F. Howard Jr., MD, professor in the UNC Department of Neurology, was principal investigator of the phase 3 trial for the experimental drug efgartigimod, developed by Belgian pharmaceutical company Argenx.

The American Academy of Neurology awarded Monica M. Diaz, MD, MS, a Clinical Research Training Scholarship in support of her research on the detection of neurodegeneration in older, cognitively impaired people with HIV.

The Duke/UNC ADRC is pleased to announce the release of three funding opportunities for researchers at Duke and UNC studying Alzheimer’s disease and related dementias. One of the awards, the REC Scholar, is also open to candidates from UNC Pembroke, North Carolina Central University, and East Carolina University.

Over 800 scientists from across the United States and overseas convened virtually for a joint Duke/UNC Alzheimer’s Disease Symposium on May 27.

NC TraCS awarded funding for a $5K-$50K grant application submitted by Yen-Yu Ian Shih, PhD.